Found 18 matching trials
A Study of HRS-4642 Monotherapy or in Combination With Adebrelimab in the Treatment of Advanced Biliary Tract Tumors.
PHASE2The study was designed to evaluate the efficacy and safety of HRS-4642 mono...
Location
Shanghai Zhongshan Hospital
Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal Adenocarcinoma
PHASE1The study is being conducted to evaluate the safety, tolerability and effic...
Location
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer
PHASE2This study will evaluate the effectiveness and safety of HRS-4642 in combin...
Location
Jiangsu Province Hospital
HRS-4642 Combined With Nimotuzumab in the Treatment of Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma
PHASE1To evaluate the safety and efficacy of HRS-4642 combined with Nimotuzumab i...
Status
Active Not Recruiting
Location
West China Hospital, Sichuan University
A Study of HRS-4642 in Combination With Antineoplastic Agents in Advanced Solid Tumors
PHASE1To evaluate the safety and preliminary efficacy of HRS-4642 in combination ...
Location
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Neoadjuvant HRS-4642 Plus Chemotherapy With or Without Immunotherapy for Pancreatic Cancer
PHASE2To evaluate the safety and efficacy of neoadjuvant HRS-4642 plus chemothera...
Location
Multiple Locations
HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer
PHASE2To evaluate the safety and efficacy of HRS-4642 in Combination With AG for ...
Location
Ruijin Hospital Shanghai Jiaotong University School of Medicine
Clinical Trial of HRS-4642 Plus SHR-A2102 in Patients With Advanced Solid Tumors
PHASE1The purpose of this study is to observe and evaluate the efficacy and safet...
Location
Henan Cancer Hospital
HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients
PHASE2This study is a single-arm phase II clinical study to include 32 patients w...
Location
First Affiliated Hospital of Zhejiang University Schlool of Medicine
An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic Cancer
PHASE2To evaluate the safety and efficacy of HRS-4642 in combination with immunot...
Location
Zhongshan Hospital, Fudan University